NEW YORK (GenomeWeb) – Illumina will join the S&P 500 Index following the close of trading on Nov. 18. The firm also will be added to the S&P 500 Global Industry Classification Standard Life Science Tools & Services Sub-Industry index. Illumina is replacing Sigma-Aldrich, which is nearing completion of its acquisition by Merck KGaA, in the S&P 500.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.